Funding for this research was provided by:
Västra Götalandsregionen (ALFGBG-725291)
Text and Data Mining valid from 2020-02-14
Received: 11 November 2019
Accepted: 11 February 2020
First Online: 14 February 2020
Ethics approval and consent to participate
: Dr. no 673–14 (2014-09-24), Ethical Regional Board of Gothenburg, Gothenburg, Sweden. The ethics committee belongs to the Swedish Ethical Review Authority at the Government Offices of Sweden.Study nurse obtained written and verbal informed consent from study participants.
: Does not apply.
: Professor Eliasson reports personal fees (expert panels, lectures) from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Mundipharma, Navamedic, NovoNordisk, RLS Global, and grants and personal fees from Sanofi, all outside the submitted work.